Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Elife
|
September 4, 2019
Androgen-regulated transcription of <i>ESRP2</i> drives alternative splicing patterns in prostate cancer
Jennifer Munkley, Ling Li, S R Gokul Krishnan, et al.
Communications Biology
|
March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
Rebecca Garnham, Daniel Geh, Ryan Nelson, et al.
The New England Journal of Medicine
|
January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Yael C Cohen, Hila Magen, Moshe Gatt, et al.
Cancer Medicine
|
May 19, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors
Kayla Bastian, Margarita Orozco-Moreno, Huw Thomas, et al.
Ebiomedicine
|
May 21, 2024
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco-Moreno, Emily Archer Goode, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma
Sathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
The New England Journal of Medicine
|
December 8, 2025
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
Shaji Kumar, María-Victoria Mateos, Jing Christine Ye, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Older patients with myeloma derive similar benefit from autologous transplantation
Manish Sharma, Mei-Jie Zhang, Xiaobo Zhong, et al.
The Journal of Pathology
|
August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene
|
February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
Emma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Elife
|
September 4, 2019
Androgen-regulated transcription of <i>ESRP2</i> drives alternative splicing patterns in prostate cancer
Jennifer Munkley, Ling Li, S R Gokul Krishnan, et al.
Communications Biology
|
March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
Rebecca Garnham, Daniel Geh, Ryan Nelson, et al.
The New England Journal of Medicine
|
January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Yael C Cohen, Hila Magen, Moshe Gatt, et al.
Cancer Medicine
|
May 19, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors
Kayla Bastian, Margarita Orozco-Moreno, Huw Thomas, et al.
Ebiomedicine
|
May 21, 2024
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco-Moreno, Emily Archer Goode, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma
Sathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.
The New England Journal of Medicine
|
December 8, 2025
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
Shaji Kumar, María-Victoria Mateos, Jing Christine Ye, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Older patients with myeloma derive similar benefit from autologous transplantation
Manish Sharma, Mei-Jie Zhang, Xiaobo Zhong, et al.
The Journal of Pathology
|
August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene
|
February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
Emma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Page
of 9